MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway

被引:274
作者
Lou, Guohua [1 ]
Chen, Liang [2 ]
Xia, Caixia [3 ]
Wang, Weina [1 ]
Qi, Jinjin [1 ]
Li, Aichun [1 ]
Zhao, Liying [4 ]
Chen, Zhi [1 ]
Zheng, Min [1 ,4 ]
Liu, Yanning [1 ,4 ]
机构
[1] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis, Natl Clin Res Ctr Infect Dis,Affiliated Hosp 1,Co, 79 Qingchun Rd,6A-17, Hangzhou 310003, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Thyroid Dis Diag & Treatment Ctr, Sch Med, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Infect Dis, Sch Med, Hangzhou, Peoples R China
[4] Zhejiang Univ, Affiliated Hosp 2, Dept Infect Dis, Sch Med, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Mesenchymal stem cell; Exosome; miR-199a-3p; Hepatocellular carcinoma; Chemosensitivity; THERAPY; GROWTH; PROLIFERATION; SENSITIVITY; METASTASIS;
D O I
10.1186/s13046-019-1512-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background MiR-199a-3p (miR-199a) can enhance the chemosensitivity of hepatocellular carcinoma (HCC). Because of the easy degradation of miRNA by direct infusion, effective vehicle-mediated delivery of miR-199a may represent a new strategy for improving HCC chemotherapy. Considering mesenchymal stem cell (MSC)-derived exosomes as promising natural nanovectors for drug and molecule delivery, we aimed to determine whether exosomes from adipose tissue-derived MSCs (AMSCs) could be used to deliver miR-199a and improve HCC chemosensitivity. Methods MiR-199a-modified AMSCs (AMSC-199a) were constructed by miR-199a lentivirus infection and puromycin selection. MiR-199-modified exosomes (AMSC-Exo-199a) were isolated from the supernatant of AMSC-199a and were assessed by transmission electron microscopy, nanoparticle tracking analysis, and flow cytometry analysis. The expression levels of miR-199a in HCC samples, AMSCs, exosomes, and HCC cells were quantified by real-time PCR. The effects of AMSC-Exo-199a on HCC chemosensitivity were determined by cell proliferation and apoptosis assays and by i.v. injection into orthotopic HCC mouse models with doxorubicin treatment. MTOR, p-4EBP1 and p-70S6K levels in HCC cells and tissues were quantified by Western blot. Results AMSC-Exo-199a had the classic characteristics of exosomes and could effectively mediate miR-199a delivery to HCC cells. Additionally, AMSC-Exo-199a significantly sensitized HCC cells to doxorubicin by targeting mTOR and subsequently inhibiting the mTOR pathway. Moreover, i.v.-injected AMSC-Exo-199a could distribute to tumor tissue and markedly increased the effect of Dox against HCC in vivo. Conclusions AMSC-Exo-199a can be an effective vehicle for miR-199a delivery, and they effectively sensitized HCC to chemotherapeutic agents by targeting mTOR pathway. AMSC-Exo-199a administration may provide a new strategy for improving HCC chemosensitivity.
引用
收藏
页数:9
相关论文
共 34 条
[1]   miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model [J].
Callegari, Elisa ;
D'Abundo, Lucilla ;
Guerriero, Paola ;
Simioni, Carolina ;
Elamin, Bahaeldin K. ;
Russo, Marta ;
Cani, Alice ;
Bassi, Cristian ;
Zagatti, Barbara ;
Giacomelli, Luciano ;
Blandamura, Stella ;
Moshiri, Farzaneh ;
Ultimo, Simona ;
Frassoldati, Antonio ;
Altavilla, Giuseppe ;
Gramantieri, Laura ;
Neri, Luca Maria ;
Sabbioni, Silvia ;
Negrini, Massimo .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 11 :485-493
[2]   Origins and Mechanisms of miRNAs and siRNAs [J].
Carthew, Richard W. ;
Sontheimer, Erik J. .
CELL, 2009, 136 (04) :642-655
[3]   MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1 [J].
Chen, Lei ;
Cao, Hongwen ;
Feng, Yigeng .
WORLD JOURNAL OF UROLOGY, 2018, 36 (03) :357-365
[4]   Flavonoids as Natural Anti-Inflammatory Agents Targeting Nuclear Factor-Kappa B (NFκB) Signaling in Cardiovascular Diseases: A Mini Review [J].
Choy, Ker Woon ;
Murugan, Dharmani ;
Leong, Xin-Fang ;
Abas, Razif ;
Alias, Aspalilah ;
Mustafa, Mohd Rais .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[5]   miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8 [J].
Cui, Yajie ;
Wu, Fengqin ;
Tian, Defu ;
Wang, Ting ;
Lu, Tianjie ;
Huang, Xiying ;
Zhang, Peilian ;
Qin, Li .
ONCOLOGY REPORTS, 2018, 39 (04) :1649-1657
[6]   CURRENT CONCEPTS Hepatocellular Carcinoma [J].
El-Serag, Hashem B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) :1118-1127
[7]   MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM) [J].
Fan, Xuelong ;
Zhou, Shangcheng ;
Zheng, Miao ;
Deng, Xiyun ;
Yi, Yinsha ;
Huang, Tieniu .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 :507-514
[8]   MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells [J].
Fornari, Francesca ;
Milazzo, Maddalena ;
Chieco, Pasquale ;
Negrini, Massimo ;
Calin, George Adrian ;
Grazi, Gian Luca ;
Pollutri, Daniela ;
Croce, Carlo Maria ;
Bolondi, Luigi ;
Gramantieri, Laura .
CANCER RESEARCH, 2010, 70 (12) :5184-5193
[9]   MicroRNAs: New Tools for Diagnosis, Prognosis, and Therapy in Hepatocellular Carcinoma? [J].
Giordano, Silvia ;
Columbano, Amedeo .
HEPATOLOGY, 2013, 57 (02) :840-847
[10]   Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma [J].
Hou, Jin ;
Lin, Li ;
Zhou, Weiping ;
Wang, Zhengxin ;
Ding, Guoshan ;
Dong, Qiongzhu ;
Qin, Lunxiu ;
Wu, Xiaobing ;
Zheng, Yuanyuan ;
Yang, Yun ;
Tian, Wei ;
Zhang, Qian ;
Wang, Chunmei ;
Zhang, Qinghua ;
Zhuang, Shi-Mei ;
Zheng, Limin ;
Liang, Anmin ;
Tao, Wenzhao ;
Cao, Xuetao .
CANCER CELL, 2011, 19 (02) :232-243